Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dr. Sinatra is a leading consumer health brand specializing in integrative cardiology and nutritional supplements. Founded by the late Dr. Stephen Sinatra, a board-certified cardiologist, the company is a pioneer in the field of metabolic cardiology, focusing on the synergistic effects of specific nutrients on heart health. The brand's product portfolio is centered around the "Awesome Foursome"—Coenzyme Q10, L-Carnitine, Magnesium, and D-Ribose—which are designed to support mitochondrial energy production in the heart. Currently operating as a flagship brand under the Healthy Directions umbrella, the company provides science-based supplements, vitamins, and educational resources to consumers. Its mission remains focused on combining conventional medical wisdom with natural therapies to promote cardiovascular wellness and longevity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stephen Sinatra.